Clonal Hematopoiesis: Crossroads of Aging, Cardiovascular Disease, and Cancer: JACC Review Topic of the Week.

[1]  Daniel E Forman,et al.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Journal of the American College of Cardiology.

[2]  P. Libby,et al.  Inflammation: a common contributor to cancer, aging, and cardiovascular diseases—expanding the concept of cardio-oncology , 2019, Cardiovascular research.

[3]  Carolyn M. Reilly,et al.  Cardio-Oncology: Vascular and Metabolic Perspectives A Scientific Statement From the American Heart Association , 2019, Circulation.

[4]  D. Levy,et al.  Hemothelium, Clonal Hematopoiesis of Indeterminate Potential, and Atherosclerosis. , 2019, Circulation.

[5]  E. Papaemmanuil,et al.  Managing Clonal Hematopoiesis in Patients With Solid Tumors. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  P. Libby,et al.  CHIPping Away at the Pathogenesis of Heart Failure. , 2019, JAMA cardiology.

[7]  B. Brüne,et al.  Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure , 2018, JAMA cardiology.

[8]  Peter J. Campbell,et al.  Somatic mutant clones colonize the human esophagus with age , 2018, Science.

[9]  P. Libby,et al.  Jak-ing Up the Plaque's Lipid Core…and Even More. , 2018, Circulation research.

[10]  A. Tall,et al.  Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2V617F Mice , 2018, Circulation research.

[11]  M. Ladanyi,et al.  Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors , 2018, JAMA oncology.

[12]  N. Rosenthal,et al.  The Macrophage in Cardiac Homeostasis and Disease: JACC Macrophage in CVD Series (Part 4). , 2018, Journal of the American College of Cardiology.

[13]  E. V. van Beek,et al.  Coronary CT Angiography and 5‐Year Risk of Myocardial Infarction , 2018, The New England journal of medicine.

[14]  P. Libby,et al.  CHIP (Clonal Hematopoiesis of Indeterminate Potential). , 2018, Circulation.

[15]  H. Amthauer,et al.  JAK2-V617F promotes venous thrombosis through &bgr;1/&bgr;2 integrin activation , 2018, The Journal of clinical investigation.

[16]  B. Ebert,et al.  Predicting progression to AML , 2018, Nature Medicine.

[17]  K. Ballman,et al.  Somatic mutations precede acute myeloid leukemia years before diagnosis , 2018, Nature Medicine.

[18]  Stanley W. K. Ng,et al.  Prediction of acute myeloid leukaemia risk in healthy individuals , 2018, Nature.

[19]  R. Levine,et al.  Concise Review: Age‐Related Clonal Hematopoiesis: Stem Cells Tempting the Devil , 2018, Stem cells.

[20]  Yakir A Reshef,et al.  Insights about clonal hematopoiesis from 8,342 mosaic chromosomal alterations , 2018, Nature.

[21]  K. Walsh,et al.  CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease , 2018, Circulation research.

[22]  S. Mccarroll,et al.  Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms , 2018, Science Translational Medicine.

[23]  Christopher A. Miller,et al.  Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential , 2018, Nature Communications.

[24]  P. Libby,et al.  The Present and FutureReview Topic of the WeekInterleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond , 2017 .

[25]  M. Ladanyi,et al.  Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes. , 2017, Cell stem cell.

[26]  S. Gabriel,et al.  Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease , 2017, The New England journal of medicine.

[27]  Matthew A. Cooper,et al.  Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice , 2017, Science.

[28]  R. Green,et al.  Genomic sequencing in clinical practice: applications, challenges, and opportunities , 2016, Dialogues in clinical neuroscience.

[29]  Nicholas Eriksson,et al.  Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms. , 2016, Blood.

[30]  P. Libby,et al.  Mechanisms of Myeloid Cell Modulation of Atherosclerosis , 2016, Microbiology spectrum.

[31]  P. Libby,et al.  Leukocytes Link Local and Systemic Inflammation in Ischemic Cardiovascular Disease: An Expanded "Cardiovascular Continuum". , 2016, Journal of the American College of Cardiology.

[32]  B. Ebert,et al.  Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. , 2015, Blood.

[33]  A. Viale,et al.  Somatic mutations in leukocytes infiltrating primary breast cancers , 2015, npj Breast Cancer.

[34]  M. Stratton,et al.  High burden and pervasive positive selection of somatic mutations in normal human skin , 2015, Science.

[35]  M. McCarthy,et al.  Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.

[36]  M. Nahrendorf,et al.  Leukocyte Behavior in Atherosclerosis, Myocardial Infarction, and Heart Failure , 2013, Science.

[37]  Jennifer G. Robinson,et al.  The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis , 2012, The Lancet.

[38]  Mark Woodward,et al.  Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies , 2012 .